---

BIOASSAY - Viva Questions & Answers for MD Pharmacology

---

SECTION 1: DEFINITION AND FUNDAMENTALS

---

---

---

• The test and standard preparations must have the same pharmacological mode of action
• The active principle should produce the same measured response across all animal species used
• The dose-response curves (DRC) of the standard and test must be parallel (graded assays), so a potency ratio can be calculated
• The method must be reliable, sensitive, specific, and reproducible
• Individual biological variation must be minimized or accounted for
• The measured response must be the biological activity of interest

---

1. When the active principle has pharmacological activity but its chemical structure is unknown (e.g., long-acting thyroid stimulants - LATS)
2. When the active substance cannot be isolated or purified by chemical means
3. When chemical assays are unavailable or inadequate
4. When a mixture of substances with the same pharmacological action needs to be assayed as a whole (e.g., digitalis)
5. When biological activity of a drug must be standardized (e.g., insulin, heparin, oxytocin, ergot alkaloids, tubocurarine)
6. For quality control of biological products (vaccines, sera, antitoxins)
7. When physicochemical analysis is technically not feasible

---

• Highly sensitive and specific
• Measures actual pharmacological activity
• Simple and fast procedure for certain assays
• Possible with small volumes of test solution
• Only method when chemical structure is unknown

• Loss of tissue sensitivity (tachyphylaxis)
• Biological and methodological errors
• Time-consuming
• Dose-ranging studies are not always feasible
• Inter-animal variation

---

SECTION 2: TYPES OF BIOASSAY

---

1. Quantal (Direct Endpoint) Assay - "all or none" response
2. Graded (Quantitative) Assay - response proportional to dose

1. Matching / Direct matching (Bracketing) method
2. Interpolation method
3. Multiple point assays:
   • Three-point assay
   • Four-point assay (most common)
   • Six-point assay
4. Cumulative dose-response method

1. In vivo assays - intact animals
2. In vitro assays - isolated tissues/organ bath

---

• The drug produces an "all or none" response - the animal either shows the full response or does not respond at all
• The threshold dose (minimum dose producing a predetermined defined response) is measured for both standard and test preparation
• The potency ratio = threshold dose of standard / threshold dose of test
• Uses different animals for different doses

• Digitalis bioassay in cats (cardiac arrest as endpoint) - cat is anaesthetized with chloralose, drug infused slowly; the volume infused when the heart stops and BP falls to zero is the lethal dose
• Digitalis in guinea pigs (cardiac arrest)
• Insulin bioassay (hypoglycemic convulsions in mice)
• Ergot alkaloids (gangrenous changes)

• Drug effects appear rapidly and are easily recognized
• Drug effect is directly proportional to dose
• Rapid endpoint detection

---

• A graded response method
• The dose of the test preparation is adjusted to produce a response that matches (equals) the response of a given dose of the standard
• The test dose is "bracketed" between two doses of the standard (one producing a slightly smaller and one producing a slightly larger response)
• Potency ratio = dose of standard / dose of test that produces matching response
• Simple but requires careful technique
• Example: Matching method for oxytocin on isolated rat uterus

---

• A dose-response curve (DRC) of the standard is plotted first
• A single (or few) responses of the test preparation are obtained
• The unknown concentration is interpolated from the standard DRC
• Assumes the shape of the DRC is the same for test and standard
• More accurate than matching; used when only small amounts of test preparation are available

---

• Two doses of the standard (S1 and S2) and two doses of the test (T1 and T2) are compared
• The doses chosen are on the linear part of the log dose-response curve
• The ratio S1:S2 = T1:T2 (equally spaced on log scale)
• The DRCs for standard and test must be parallel
• Potency ratio is calculated by comparing the equieffective doses

• Provides a check on parallelism of DRCs (validity of the assay)
• More precise and statistically reliable than two-point or matching methods
• Allows calculation of confidence limits
• Standard method recommended by pharmacopoeias

---

SECTION 3: ORGAN BATH AND ISOLATED TISSUE PREPARATION

---

1. Organ bath chamber - glass vessel containing physiological salt solution (PSS) at the appropriate temperature; typically 10-50 mL capacity
2. Kymograph / recording drum - records tissue response; standard speed = 1 revolution/96 minutes (0.014 rpm); slow-contracting tissues use low speed, fast-contracting use higher speed; glossy side faces outward
3. Sherrington recording drum
4. Lever - Type 1 lever used in in vitro bioassays; must be lightweight, fine, and rigid to avoid bending; has a stylus (writing point)
5. Aerator - bubbles carbogen (95% O₂ + 5% CO₂) or oxygen through the bath
6. Water jacket - maintains constant temperature

• Mx = Distance (fulcrum to writing point) / Distance (fulcrum to tissue attachment) = A/B
• Slow-contracting tissue → high magnification (10-15×)
• Fast-contracting tissue → low magnification (5-10×)

---

• Provides ionic supply (Na⁺, K⁺, Ca²⁺, Mg²⁺, Cl⁻, HCO₃⁻, HPO₄²⁻)
• Provides nutritional supply (glucose as energy source)
• Maintains osmotic pressure
• Maintains pH (buffering)
• Prepared in distilled or deionized water

---

• Allow adequate dose cycle time: 3 minutes for fast-contracting tissues, 5 minutes for slow-contracting tissues
• Perform at least two tissue washes between doses
• Use lower concentrations where possible
• Avoid drugs known to cause tachyphylaxis (e.g., histamine, 5-HT) or account for it in the design

---

• Dose cycle: The time gap between successive drug additions to the organ bath
  • Fast-contracting tissues: 3 minutes
  • Slow-contracting tissues: 5 minutes
  • Must include at least 2 tissue washes
• Contact time: The duration for which the tissue is in contact with the drug before washing out

---

---

SECTION 4: SPECIFIC BIOASSAY EXAMPLES

---

• Type: Quantal (endpoint) assay
• Animal: Mice (male or female, uniform weight)
• Endpoint: Hypoglycemic convulsions (or loss of righting reflex)
• Method: Groups of fasted mice receive graded doses of standard and test insulin SC; the dose causing convulsions in 50% of animals is the ED50; potency ratio = ED50 standard / ED50 test
• Unit: International Unit (IU) - defined relative to WHO International Standard
• Historical note: First standardized using the mouse convulsion method

---

• Type: Quantal (direct endpoint) assay
• Animal: Cat (anaesthetized with urethane or chloralose) - classic method
• Endpoint: Cardiac arrest (cessation of heartbeat with fall of BP to zero)
• Method: Cat is anaesthetized and blood pressure is recorded; digitalis preparation is slowly infused IV; the dose at which cardiac arrest occurs is the lethal dose; compared with standard
• Alternative: Guinea pig cardiac arrest method
• Significance: Digitalis glycosides have a narrow therapeutic index and cannot be reliably quantified chemically since biological activity varies by preparation

---

• Type: Graded assay (matching/bracketing method)
• Tissue: Isolated rat uterus (estrogen-primed) in organ bath containing De-Jalon solution at 32°C
• Response measured: Uterine contraction (amplitude and frequency)
• Method: Standard and test oxytocin doses are compared; the dose of test that matches the response of the standard is determined
• Unit: International Unit - defined by WHO International Standard

---

• Type: Graded assay
• Tissue: Guinea pig ileum in Tyrode solution at 37°C
• Response: Contraction of ileum (histamine causes contraction of intestinal smooth muscle)
• Reference: Katzung's Basic and Clinical Pharmacology notes that "histamine-induced contraction of guinea pig ileum is a standard bioassay for this amine"
• Potency estimated by comparison with standard histamine

---

• Type: Graded assay (in vivo or in vitro)
• Tissue (in vitro): Frog rectus abdominis muscle
• Response: Neuromuscular blockade (inhibition of ACh-induced contraction)
• In vivo method: Cat head-drop method - dose that causes a specified degree of head drop in an anaesthetized cat
• Tubocurarine causes competitive neuromuscular blockade; its potency is compared with standard

---

SECTION 5: STATISTICAL AND TECHNICAL ASPECTS

---

• Potency ratio > 1: test preparation is more potent than standard
• Potency ratio < 1: test preparation is less potent than standard
• Potency ratio = 1: equal potency

---

• For a valid graded bioassay, the log dose-response curves (LDRCs) of the standard and test preparation must be parallel
• Parallelism confirms that the two preparations have the same mode of action and the only difference is potency
• Non-parallel curves indicate either different mechanisms of action or an invalid assay
• In a four-point assay, parallelism is tested by comparing the slopes of the two lines
• If lines are not parallel, the potency ratio cannot be validly calculated

---

• Inter-animal / inter-tissue variation (genetic, age, sex differences)
• Tachyphylaxis (rapid loss of tissue sensitivity)
• Tissue fatigue
• Disease in animals

• Inaccurate preparation of solutions (dilution errors)
• Temperature variation of bath
• Inadequate aeration of PSS
• Improper lever magnification
• Wrong kymograph speed
• Contamination of solutions

• Small sample size
• Inadequate randomization
• Failure to test for parallelism

---

1. Use a crossover design - same animal/tissue receives both standard and test
2. Use randomization of treatment allocation
3. Use homogeneous groups of animals (same species, strain, age, sex, weight)
4. Use Latin square design or randomized block design for multiple treatments
5. Use the four-point (or higher) assay design - allows statistical testing
6. Use sufficient replications
7. Appropriate wash-out periods between doses

---

• The WHO International Standard (or International Reference Preparation) is the primary reference material for biological standardization
• The International Unit (IU) is defined as the specific biological activity contained in a defined amount of the International Standard
• For example: 1 IU of insulin is the activity of 0.0347 mg of the WHO International Standard for insulin
• National standards are calibrated against the WHO standard
• This ensures that potency estimates from different laboratories worldwide are comparable

---

SECTION 6: MODERN PERSPECTIVES

---

• Imprecision: High inherent biological variability
• Slow: Time-consuming setup and execution
• Labor intensive: Requires skilled personnel and animal facilities
• Ethical concerns: Use of live animals (3Rs principle - Replace, Reduce, Refine)
• Tachyphylaxis: Limits number of assays per tissue
• Not specific enough for complex biological matrices
• Immunoassays (RIA, ELISA) offer superior sensitivity, precision, throughput, and avoid animal use - Tietz Textbook of Laboratory Medicine notes that "Bioassays tend to be imprecise and are now rarely used in clinical medicine"

---

1. Standardization of biological products where no chemical method exists (e.g., certain vaccines, botulinum toxin - mouse lethality bioassay remains the gold standard for BoNT, though alternatives like Endopep-MS are emerging)
2. Quality control of insulin, heparin, oxytocin, streptokinase batches by regulatory bodies
3. Research purposes - receptor characterization, pharmacological profiling
4. Detection of functional antibodies (e.g., thyroid-stimulating immunoglobulins - TSI requires a cell-based bioassay where patient serum is added to thyroid follicular cells; Henry's Clinical Diagnosis confirms this as the classic method for TSI)
5. Toxicology - evaluation of safety of chemicals, pesticides, environmental pollutants
6. Factor level assays in coagulation (bioassay measures ability of test plasma to normalize substrate-deficient plasma)

---

• Tietz notes that in vitro bioassays often "measure responses proximal or distal to a second messenger such as stimulation of cAMP formation"

---

• Three-point assay: One dose of standard + two doses of test (or two doses of standard + one dose of test); less precise than four-point
• Four-point assay: Two doses of standard (S1, S2) + two doses of test (T1, T2) - the preferred method; allows testing of parallelism and provides a valid statistical estimate of potency with confidence limits
• Six-point assay: Three doses each of standard and test - most precise, used for pharmacopoeial assays requiring high accuracy

---

• LD50: The dose of a drug that is lethal to 50% of animals in a given population under defined conditions. Determined by the quantal bioassay method.
• ED50: The dose that produces a specified (usually 50%) effect in 50% of the test population. Used in quantal bioassays.
• Therapeutic index (TI): TI = LD50 / ED50. A measure of drug safety - a higher TI indicates a wider margin of safety. (Note: clinically, TI is better measured as TI = TD50/ED50 using toxic rather than lethal dose.)

---

QUICK RECALL LIST: Key Drug-Tissue-PSS Combinations

---

---

COMPLETE STEPS OF BIOASSAY METHODS

---

TYPE 1: QUANTAL (DIRECT ENDPOINT) ASSAY

Example: Bioassay of Digitalis in Cat

---

• Select healthy adult cats of uniform weight (2-3 kg), preferably male
• Fast the animal for 12-24 hours before the experiment
• Weigh the animal accurately

• Anaesthetize the cat with alpha-chloralose (80 mg/kg IV) or urethane
• The cat is placed on the operation table in dorsal recumbency
• Confirm adequate depth of anaesthesia (no pedal withdrawal reflex)

• Make a midline incision in the neck
• Expose and cannulate the trachea (for maintenance of airway)
• Cannulate the femoral vein (or jugular vein) for drug administration
• Cannulate the carotid artery and connect to a mercury manometer / pressure transducer to record blood pressure (BP)
• Connect ECG leads or use BP tracing to monitor heart rate

• Allow the animal to stabilize for 30 minutes after surgery
• Record baseline BP and heart rhythm
• Ensure the preparation is stable before starting

• Connect a calibrated infusion pump or syringe to the venous cannula
• Prepare the standard digitalis preparation (known potency) and test preparation (unknown potency) in separate syringes at known concentrations (e.g., in normal saline)

• Begin slow, continuous IV infusion of the standard preparation at a constant rate (e.g., 1 mL/min)
• Continue infusion while monitoring BP and cardiac rhythm continuously

• The endpoint = cardiac arrest (complete cessation of heartbeat + BP falls to zero)
• Note the exact volume infused at the moment of cardiac arrest
• Calculate the total dose given = concentration × volume infused = lethal dose (LD) for standard

• Allow sufficient washout/recovery time OR use a fresh animal
• Repeat the identical infusion procedure with the test preparation
• Note volume infused at cardiac arrest
• Calculate lethal dose for test preparation

• Potency ratio = LD of standard / LD of test
• If LD of standard = 1.0 mg/kg and LD of test = 0.5 mg/kg → potency ratio = 2 (test is twice as potent)
• Repeat in multiple animals and calculate mean ± SEM
• Express potency in units relative to the WHO International Standard

• Record all data: animal weight, doses, volumes, endpoint times
• Present results as mean potency ratio with confidence limits

---

Other Examples of Quantal Assay:

---

TYPE 2: GRADED ASSAY - MATCHING (BRACKETING) METHOD

Example: Bioassay of Oxytocin using Rat Uterus

---

• Select mature female Wistar rats (150-200 g)
• To sensitize the uterus: inject estradiol benzoate (1 mg/kg SC) 18-24 hours before the experiment (estrogen priming makes uterus more responsive to oxytocin)
• Fast the rat for 2 hours before experiment

• Sacrifice the rat by cervical dislocation or CO₂ asphyxiation
• Open the abdomen with a midline incision
• Identify the uterus (Y-shaped structure in the pelvic cavity, two uterine horns)
• Carefully dissect out the uterus, avoiding excessive stretching or trauma
• Place immediately in cold De-Jalon solution

• Remove adhering fat and connective tissue gently with scissors
• Cut a uterine horn strip of approximately 2-3 cm length
• Tie a thread at both ends of the strip using fine silk thread (do not constrict the lumen)
• Keep the tissue in De-Jalon solution until mounting

• Fill the organ bath (10-25 mL capacity) with De-Jalon solution maintained at 32°C (rat uterus is a slow-contracting tissue)
• Bubble with 95% O₂ + 5% CO₂ (carbogen) or oxygen at a slow rate
• Equilibrate the bath temperature for 15 minutes before mounting

• Attach the lower thread to the fixed hook at the bottom of the organ bath
• Attach the upper thread to the lever (Type 1 lever with high magnification: 10-15×, appropriate for slow-contracting tissue)
• Apply a resting tension of 0.5-1 g (using a tension adjuster)
• Lower the preparation into the bath so it is fully submerged

• Allow the tissue to equilibrate for 30-45 minutes in De-Jalon solution
• During this time, wash the bath (change PSS) every 10-15 minutes
• Set kymograph at slow speed (appropriate for slow-contracting uterus)
• Allow the tissue to reach a stable baseline with minimal spontaneous activity

• Prepare standard oxytocin in De-Jalon solution at known concentrations (e.g., 0.01, 0.02, 0.04, 0.08 mU/mL)
• Prepare test oxytocin at concentrations estimated to be in the same range
• Label all syringes clearly

• Add a trial dose of standard to the bath; observe the response (uterine contraction height in mm on kymograph)
• Select a standard dose that produces a moderate, reproducible contraction (approximately 40-60% of maximum response) - call this dose S₁
• Choose a second standard dose (S₂) approximately double of S₁ to bracket the expected test response
• Wash the bath after each dose; wait for the tissue to return to baseline before next dose
• Dose cycle: 5 minutes minimum (slow-contracting tissue) with at least 2 washes

• Add dose T (test preparation) to the bath; record the contraction height
• If T response falls between S₁ and S₂ responses → the dose is "bracketed" - record the T response
• Wash; wait; repeat until consistent results

• Adjust the dose of test preparation up or down until it produces a response that exactly matches the response of S₁ (or the chosen standard dose)
• The matched test dose = T₁ (equivalent dose)

• Potency ratio = S₁ / T₁ (in mL or concentration units)
• If standard dose = 0.02 mU/mL produces the same response as test dose 0.04 mU/mL → test is half as potent
• Repeat 4-6 cycles; calculate mean potency ratio

• Trace kymograph record; label each response with drug, dose, time
• Report potency ratio with standard deviation and 95% confidence limits

---

TYPE 3: GRADED ASSAY - INTERPOLATION METHOD

Example: Bioassay of Histamine using Guinea Pig Ileum

---

• Select a healthy guinea pig (300-500 g), fasted for 24 hours
• Sacrifice by cervical dislocation or CO₂

• Open the abdomen; identify the ileum (last part of small intestine before cecum)
• Avoid the cecum (it contains bacteria)
• Cut a 2-3 cm segment of ileum
• Flush gently with warm Tyrode solution using a syringe (to remove gut contents)
• Tie threads at both ends; keep in warm Tyrode solution

• Fill organ bath (10-25 mL) with Tyrode solution at 37°C
• Aerate with oxygen or carbogen
• Use Type 1 lever with magnification 5-10× (fast-contracting tissue)

• Mount the ileum strip in the organ bath as described above
• Apply resting tension of 0.5-1 g
• Set kymograph at fast speed (fast-contracting tissue)

• Allow 30-minute equilibration with regular PSS changes
• Confirm stable baseline with minimal spontaneous activity

• Add increasing concentrations of standard histamine (e.g., 0.01, 0.02, 0.04, 0.08, 0.16, 0.32 μg/mL) to the bath, one at a time
• After each dose: record contraction height (mm); then wash bath; wait for baseline to return (dose cycle: 3 minutes for ileum)
• Plot log dose (X-axis) vs. response/contraction height (Y-axis)
• This gives a sigmoidal or linear (on log scale) DRC for standard

• Add the test histamine preparation at one or two concentrations
• Record the response (contraction height in mm)
• Do NOT adjust the dose - simply record whatever response is produced

• On the standard DRC graph, find the point on the Y-axis corresponding to the test response height
• Drop a perpendicular to the X-axis (log dose axis)
• Read off the equivalent standard dose that would produce that same response
• This is the "equivalent dose" of standard = potency of test preparation

• If test dose of 0.04 μg/mL gives a response that, when interpolated on the standard DRC, corresponds to a standard dose of 0.02 μg/mL → test preparation is half as potent
• Potency ratio = equivalent standard dose / actual test dose used

• Ensure the test response falls within the linear portion of the standard DRC (not at top or bottom plateau)
• If not, adjust test concentration and repeat

---

TYPE 4: FOUR-POINT (TWO DOSE) ASSAY

Example: Bioassay of 5-HT (Serotonin) using Rat Fundal Strip

---

• Select adult Wistar rats (200-250 g), fasted for 24 hours
• Sacrifice by cervical dislocation

• Open abdomen; locate stomach fundus (upper, rounded part)
• Cut the fundic region; place in Tyrode solution
• Open the fundus along the greater curvature
• Cut a longitudinal strip of fundal wall (2-3 cm × 3-5 mm)
• Thread at both ends; keep in warm Tyrode solution

• Tyrode solution at 37°C, oxygenated
• Mount in the organ bath; apply resting tension 1 g
• Lever magnification: 5-10× (medium contracting speed)
• Set kymograph at appropriate speed

• 30-45 minutes; change PSS every 10-15 minutes
• Confirm stable baseline

• From preliminary trials, establish the dose-response relationship
• Choose two doses of standard 5-HT (S₁ and S₂) and two doses of test preparation (T₁ and T₂) such that:
  • S₁ and T₁ produce LOW responses (e.g., 30-40% max)
  • S₂ and T₂ produce HIGH responses (e.g., 60-70% max)
  • S₁:S₂ ratio = T₁:T₂ ratio (equally spaced on log scale, e.g., ratio of 1:2)
  • All four doses fall on the linear portion of the log dose-response curve

• Administer the four doses in a randomized order or use a Latin square design (to eliminate order effect and tissue fatigue)
• Typical sequence (randomized): S₁ → T₁ → S₂ → T₂ → S₁ → T₁ → S₂ → T₂ (repeat 4-6 times = 4-6 complete cycles)
• After each dose: record response height; wash bath; dose cycle = 3-5 minutes with 2 washes; wait for full baseline recovery

• Plot log dose vs. mean response for standard (S₁, S₂) and test (T₁, T₂) on the same graph
• Draw the best-fit straight lines through the two pairs of points
• Test whether the two lines are parallel (same slope):
  • If parallel → valid assay; proceed to calculate potency ratio
  • If not parallel → assay is invalid (different mechanisms or technical error)

• The horizontal distance between the two parallel lines on the log dose-response graph = log M (log potency ratio)
• M = antilog of the horizontal distance
• Alternatively, using the formula:

M = (Mean response of Standard - Mean response of Test) / Common slope of DRC

• Potency ratio M is then calculated from this expression

• Calculate 95% confidence limits using Fieller's theorem or standard statistical methods
• Express result as: Potency = X IU/mg (95% CI: lower - upper)

• Label kymograph tracing with all doses, responses, and timing
• Tabulate all responses; perform ANOVA or appropriate statistical test

---

TYPE 5: IN VIVO GRADED ASSAY

Example: Bioassay of Acetylcholine / Adrenaline on Blood Pressure in Cat

---

• Adult cat (2-3 kg); fasted overnight
• Weigh accurately

• Inject pentobarbitone sodium (35 mg/kg IV) or urethane (1.5 g/kg IP)
• Confirm adequate anaesthesia

• Perform tracheotomy; insert tracheal cannula; connect to room air or ventilator
• Cannulate femoral vein (for IV drug administration)
• Cannulate carotid artery (for BP recording) via mercury manometer or pressure transducer + polygraph

• Allow 20-30 minutes for stabilization after surgery
• Record stable baseline BP (normal cat BP ~120/80 mmHg)

• Inject a preliminary dose of standard ACh (or adrenaline) to assess tissue sensitivity
• Choose dose S₁ (small) producing a 20-30% fall in BP and S₂ (larger) producing a 40-60% fall in BP
• Allow BP to return to baseline between each injection
• Repeat same approach for test preparation (T₁, T₂)

• Inject doses IV in a randomized or Latin square order
• Record BP change (rise or fall in mmHg) for each dose
• Allow full recovery (3-5 min between doses)

• Plot log dose vs. BP change (mm Hg)
• Check parallelism
• Calculate potency ratio as in four-point assay above

• Sacrifice the animal humanely at the end
• Record all data; calculate results with confidence limits

---

SUMMARY TABLE: Key Features of Each Method

---

HOW TO PRESENT IN VIVA - EXAMINER TIPS

1. Animal/tissue selection - species, weight, sex, preparation (fasting, hormone priming)
2. Sacrifice and isolation - method of sacrifice, how to identify and isolate the tissue
3. Organ bath setup - PSS type, temperature, aeration
4. Mounting - resting tension, lever type, magnification, kymograph speed
5. Equilibration - duration, frequency of washing
6. Dose selection - preliminary trial, doses chosen, rationale
7. Dose administration - sequence, dose cycle, number of repeats
8. Response recording - what is measured (contraction height, BP, convulsions)
9. Calculation - potency ratio formula, parallelism check
10. Statistical analysis - confidence limits, number of animals/repeats

---

IN VITRO EXPERIMENTAL STUDY: VIVA QUESTIONS & ANSWERS

MD Pharmacology Exam

---

SECTION 1: OVERVIEW & DEFINITION

---

---

• Control: Temperature, ionic composition, pH, and drug concentration are precisely controlled
• Reproducibility: Less biological variability than intact animal experiments
• Economy: Fewer animals needed per experiment
• Direct drug access: Drug reaches the tissue directly, bypassing pharmacokinetic variables (no first-pass, no distribution)
• Mechanistic clarity: Drug effects at the tissue/receptor level can be isolated
• Ethics: Reduces the number of whole animals used (3Rs principle)
• Quantitative: Precise graded dose-response relationships can be measured

• Tissue viability decreases over time (tachyphylaxis, metabolic exhaustion)
• Does not account for neurohumoral/systemic interactions
• Cannot replicate complex in vivo pharmacokinetics
• Results may not always translate to the whole organism

---

SECTION 2: ISOLATION OF TISSUE - GENERAL PRINCIPLES

---

• Select healthy adult animal of specified species, sex, and weight range
• Fast the animal appropriately (varies by preparation):
  • Guinea pig / rat gut preparations: 24-hour fast (empties gut contents, easier dissection)
  • Rat uterus: no fasting required, but estrogen priming needed
  • Frog preparations: no fasting needed

• Use the most humane, tissue-appropriate method
• Cervical dislocation: for rats, mice (quick; avoids chemical contamination of tissue)
• CO₂ asphyxiation: for guinea pigs
• Decapitation: for frogs
• Avoid methods that contaminate the tissue with chemicals that would interfere with the assay (e.g., avoid barbiturate injection for tissues sensitive to CNS depressants)

• Work quickly to minimize ischemic damage to tissue
• Use sharp scissors and fine forceps
• Identify the target organ by its anatomical landmarks (described individually below)
• Handle gently - avoid excessive stretching, squeezing, or drying

• Place the dissected tissue immediately into a petri dish containing cold (4-10°C) physiological salt solution (PSS) appropriate for that tissue
• Cold PSS slows metabolic activity and preserves viability

• Remove excess fat, connective tissue, and adhering organs under the PSS (never in air)
• Cut the tissue to the appropriate size (typically 2-3 cm strips)
• Tie fine silk threads at both ends of the strip without constricting the lumen or cutting through the tissue

• Attach the lower thread to the fixed hook at the organ bath floor
• Attach the upper thread to the recording lever
• Apply appropriate resting tension
• Submerge fully in the PSS-filled organ bath

---

1. The tissue must be highly sensitive and specific to the drug being assayed
2. It must give a graded, reproducible response proportional to the drug concentration (or a clear all-or-none endpoint)
3. It must remain viable in the PSS for the duration of the experiment
4. The response must be reversible - tissue must recover baseline after washing
5. It must be technically feasible to isolate and mount without damage
6. Tachyphylaxis should be minimal or predictable

---

SECTION 3: IDENTIFICATION OF TISSUES

---

• Sacrifice guinea pig (250-500 g) by CO₂ or cervical dislocation
• Open the abdomen with a midline incision
• Identification landmarks:
  • Locate the cecum (large, blind-ended sac in the right lower abdomen - most prominent structure)
  • The ileum is the terminal part of the small intestine that enters the cecum (ileocecal junction)
  • It appears as a thin-walled, pinkish tube with visible peristaltic activity; smaller diameter than colon
  • The ileum runs in loops throughout the abdomen; start from the cecum and follow proximally
• Avoid: the duodenum (near stomach, thicker, more fixed), the jejunum (middle loops, slightly larger), and the cecum itself
• Cut 2-3 cm proximal to the ileocecal junction
• Flush gently with warm Tyrode solution to remove gut contents (bacteria, digestive enzymes)
• Tie threads at both ends; keep in Tyrode at 37°C

• Contains abundant histamine H₁ receptors
• Rich in smooth muscle that contracts reliably with histamine and acetylcholine
• Standard tissue for histamine bioassay and cholinergic drug studies

---

• Use estrogen-primed female Wistar rat (150-200 g)
• Priming: inject estradiol benzoate 1 mg/kg SC, 18-24 hours before experiment
• Sacrifice by cervical dislocation; open abdomen
• Identification:
  • The uterus is a Y-shaped structure in the pelvic cavity
  • Two uterine horns (cornua) arise from the body and extend laterally and superiorly toward the ovaries
  • Appears as pale pink, tubular structures with visible muscular walls
  • The ovaries (small, granular) are attached to the superior end of each horn
  • The uterine horns are distinct from the intestine - they are not looped, have no gut contents, and have visible vasculature on the surface
• Isolate one uterine horn (2-3 cm)
• Remove adhering mesometrium (mesentery of the uterus) carefully
• Tie threads; place in De-Jalon solution

---

• Sacrifice fasted rat by cervical dislocation
• Open abdomen; locate stomach (left upper quadrant, under the diaphragm)
• Identification:
  • The stomach has distinct regions:
    • Fundus = upper, rounded dome portion; gray/pale color, thin-walled - this is the target
    • Body = middle portion; pinkish
    • Pylorus = lower, thick-walled, pinkish sphincter region
  • The fundus is identified by its gray color and position above the thick pink pylorus
• Cut open the fundus along the greater curvature
• Cut a longitudinal strip 2-3 cm × 3-5 mm from the fundal wall
• Both longitudinal and circular muscle layers can be used (depends on the cut direction)
• The fundus is insensitive to histamine (important distinguishing point - remember this for viva)
• Most sensitive tissue for serotonin (5-HT) in the stomach
• Place in Tyrode solution at 37°C

---

---

• Sacrifice guinea pig; expose the neck
• The trachea lies in the midline of the neck, anterior to the esophagus
• Identification: cylindrical structure with visible cartilage rings (C-shaped, open posteriorly)
• The tracheal ring is in "D" shape - the flat side of the "D" is where the smooth muscle (trachealis muscle) runs in a straight line
• The smooth muscle is present on the posterior flat surface of the D-shaped rings
• Extract at least 6 cm of trachea
• Cut into rings or a spiral strip to expose the smooth muscle
• Used for ACh studies; insensitive to histamine

---

• Frog (100-200 g) is pithed (destroy brain and spinal cord by inserting a needle through the foramen magnum into the cranial cavity, then into the spinal canal)
• Pin the frog on a dissection board, ventral surface up
• Identification:
  • The rectus abdominis is the paired, longitudinal strap muscle running on either side of the midline of the ventral abdominal wall
  • It runs from the symphysis pubis to the sternum/pectoral girdle
  • It appears as a pale, striated (skeletal) muscle - look for the tendinous intersections (inscriptions)
  • It is a striated skeletal muscle - this is important to note, unlike all other organ bath preparations which are smooth muscle
• Make incisions to detach the muscle from its origin and insertion; keep its full length
• Tie threads; place in Frog Ringer solution at room temperature

• It is the easiest isolated tissue to handle
• Contains multiple-innervated (multijunctional) fibers → shows slow contraction → classified as slow contracting tissue
• Sensitive to ACh and neuromuscular blocking agents (d-tubocurarine)
• Used for ACh bioassay and NMB drug studies

---

• Male rat (200-250 g) is sacrificed
• Place in dorsal recumbency; open the lower abdomen/perineal region
• Identification:
  • The anococcygeus is a paired smooth muscle at the terminal colon near the anus
  • It appears as a small, fibrous-looking (tendinous) strip - "does not appear soft" like typical smooth muscle
  • It has dense adrenergic excitatory and inhibitory innervation
  • Insensitive to histamine
• Carefully dissect the muscle free; tie threads; place in Krebs solution

---

SECTION 4: PRINCIPLE OF MUSCLE CONTRACTION

---

• A stimulus (drug, nerve impulse, stretch, hormones) depolarizes the smooth muscle cell membrane
• This opens voltage-gated L-type Ca²⁺ channels in the cell membrane
• Ca²⁺ floods in from the extracellular fluid (extracellular [Ca²⁺] = ~10⁻³ M vs. intracellular [Ca²⁺] = ~10⁻⁷ M at rest)
• Ca²⁺ is also released from the sarcoplasmic reticulum (SR) - but the SR is poorly developed in smooth muscle, so most Ca²⁺ comes from outside the cell (unlike skeletal muscle where SR is the primary source)
• The latent period for Ca²⁺ diffusion = 200-300 milliseconds (much longer than skeletal muscle)

• The rising intracellular Ca²⁺ binds to calmodulin (CaM) - a small 17 kDa calcium-binding protein with 4 Ca²⁺ binding sites (EF-hand motifs)
• The Ca²⁺-calmodulin complex undergoes a conformational change
• Note: Smooth muscle has NO troponin - calmodulin replaces troponin C as the Ca²⁺ sensor

• The Ca²⁺-CaM complex binds to and activates myosin light chain kinase (MLCK)

• Active MLCK phosphorylates the regulatory light chain of the myosin head (at serine-19)
• Phosphorylation causes a conformational change in the myosin head, increasing its ATPase activity
• This allows the myosin head to bind to actin filaments and undergo cross-bridge cycling

• The phosphorylated myosin head attaches to actin → power stroke (pulls actin) → detaches → re-cocks
• ATP is hydrolyzed: ATP → ADP + Pi (provides energy for each cross-bridge cycle)
• Multiple cycles shorten the muscle = contraction
• Smooth muscle actin-myosin arrangement: actin filaments attached to dense bodies (equivalent of Z-discs); myosin filaments have side-polar cross-bridges (can pull actin in two directions simultaneously) → allows up to 80% shortening (vs. <30% in skeletal muscle)

• When stimulus ceases → Ca²⁺ channels close → Ca²⁺ is pumped back by Ca²⁺-ATPase and Na⁺/Ca²⁺ exchanger
• Intracellular Ca²⁺ falls → Ca²⁺ dissociates from calmodulin → MLCK becomes inactive
• Myosin light chain phosphatase (MLCP) dephosphorylates the myosin light chain
• Dephosphorylated myosin head cannot bind actin → cross-bridge cycling stops → relaxation

• In some smooth muscles, once full contraction is achieved, the contraction can be maintained with very little ATP expenditure
• The cross-bridge enters a "latch state" (slowly cycling, attached bridge) → sustains force at low energy cost
• This is why smooth muscle is ideal for maintaining prolonged tonic contractions (e.g., blood vessel tone)

---

• Troponin-based regulation (like skeletal) but also modulated by phosphorylation (like smooth)
• Troponin-I (cardiac isoform) is phosphorylated by cAMP-dependent PKA → decreases Ca²⁺ sensitivity → faster relaxation (lusitropic effect of sympathetic stimulation)
• Troponin-C (cardiac isoform) binds Ca²⁺ → removes tropomyosin block → allows actin-myosin interaction
• Ca²⁺-induced Ca²⁺ release (CICR) from SR via ryanodine receptors is triggered by the small Ca²⁺ influx through L-type channels (trigger Ca²⁺)

---

SECTION 5: FAST vs SLOW CONTRACTING SMOOTH MUSCLES

---

• The kymograph speed used
• The dose cycle time (interval between drug doses)
• The lever magnification used
• The physiological salt solution used

FAST CONTRACTING SMOOTH MUSCLE PREPARATIONS

• Kymograph: fast speed
• Dose cycle: 3 minutes minimum (with 2 washes)
• Lever magnification: low (5-10×)

---

SLOW CONTRACTING SMOOTH MUSCLE PREPARATIONS

• Kymograph: slow speed
• Dose cycle: 5 minutes minimum (with 2 washes)
• Lever magnification: high (10-15×)

---

• The classification depends on estrogen priming:
  • Non-estrogenized uterus (non-pregnant, low estrogen state): relatively fast contracting
  • Estrogen-primed uterus (injected with estradiol benzoate 1 mg/kg SC, 18-24 hours before): responds more slowly and with sustained contractions → classified as slow contracting
• For oxytocin bioassay, estrogen-primed rat uterus is used as a slow contracting preparation in De-Jalon solution at 32°C
• Estrogen increases:
  • Oxytocin receptor expression
  • Gap junction formation (syncytial behavior)
  • Sensitivity to contractile agents

---

• Frog rectus abdominis is striated skeletal muscle - but it behaves as a slow contracting tissue in the organ bath
• Reason: It contains predominantly multiple-innervated (multijunctional, slow-twitch) fibers - these are innervated at multiple points along their length and respond slowly to chemical stimulation
• This is in contrast to mammalian fast-twitch skeletal muscle fibers (singly-innervated, faster)
• Since it is an amphibian tissue, it functions at room temperature (unlike mammalian tissues at 37°C)
• This also means the frog Ringer solution (not Tyrode) is used

---

SECTION 6: CARDIAC MUSCLE PREPARATION

---

• Pith the frog (destroy brain and spinal cord as described above)
• This eliminates CNS and autonomic nervous system influences on the heart
• Pin on a dissection board, ventral surface up

• Cut through the skin and abdominal wall in the midline from the lower abdomen to the thorax
• Reflect the xiphoid cartilage and pectoral girdle superiorly
• The frog heart is visible in the pericardial sac (translucent covering)
• Carefully open the pericardium with fine scissors
• The frog heart has two atria and one ventricle (3-chambered)

• Sinus venosus = thin-walled, dark triangular structure at the dorsal base of the heart (pacemaker - equivalent of SA node in frogs)
• Right and left atria = two small, dark, lateral pouches at the top of the heart
• Ventricle = large, muscular, cone-shaped, lighter colored, lower portion
• Conus arteriosus = muscular outflow tract arising from the ventricle anteriorly

• Tie a thread around the aorta (do not cut)
• Insert a fine Straub cannula (bent glass cannula, specially designed for frog heart) through the aorta into the ventricle
• Secure the cannula with the ligature
• The cannula is filled with and connected to a reservoir of Ringer-Locke solution (the PSS for cardiac preparation)
• Allow the Ringer-Locke to flow through the cannula, washing out the blood

• Cut the venous connections to the sinus venosus (posterior vena cavae)
• The isolated heart now hangs from the cannula, beating spontaneously
• The fluid circulates through the cannula into the heart and drips out from the cut veins

• Connect a thread from the ventricular apex to a writing lever or transducer
• Apply very light tension (0.2-0.5 g)
• The ventricular contractions raise and lower the lever → record on kymograph as up-and-down movements (each deflection = one heartbeat)
• Record: rate (beats/min) and amplitude (force/contractility)

• Ringer-Locke solution at room temperature (amphibian heart works at room temperature)
• Components: NaCl, KCl, CaCl₂, NaHCO₃, Glucose (no Mg or phosphate)
• Fill the cannula reservoir with Ringer-Locke; allow gravity perfusion

• Allow the heart to stabilize for 15-20 minutes (baseline: normal frog heart rate ~30-60 beats/min)
• Add drug to the perfusing Ringer-Locke (or directly to the bathing fluid)
• Record changes in rate (chronotropy) and amplitude (inotropy)
• Wash out by flushing with fresh Ringer-Locke

• Study effects of cardiac glycosides (digoxin, ouabain)
• Study positive/negative chronotropic and inotropic drugs
• Study effect of ionic changes (K⁺, Ca²⁺, Na⁺)
• Demonstration of adrenaline (positive inotropic + chronotropic)
• Demonstration of acetylcholine (negative inotropic + chronotropic - vagal effects)

---

• In the Langendorff preparation, the aorta is cannulated and perfused retrogradely - perfusion fluid goes backward against the aortic flow, which forces the aortic valve shut, and the fluid instead enters the coronary ostia (coronary arteries), perfusing the myocardium directly

---

---

SECTION 7: PSS - COMPREHENSIVE COMPARISON

---

---

SECTION 8: RECORDING APPARATUS

---

• A rotating drum covered with smoked paper (or glossy/smooth paper with the smooth side facing outward)
• Speed is adjustable:
  • Slow speed for slow-contracting tissues (e.g., uterus, fundus)
  • Fast speed for fast-contracting tissues (e.g., ileum, colon)
  • Standard speed: 1 revolution per 96 minutes (0.014 rpm)
• The lever writes on the drum as the tissue contracts and relaxes
• Modern equivalents: digital transducers connected to data acquisition systems (PowerLab, etc.)

• Type 1 lever is used in in vitro organ bath bioassays
• Must be: lightweight, fine, and rigid (to avoid bending during recording)
• Components:
  • Fulcrum = pivot point
  • Stylus = writing point on the far end
  • Tissue attachment point = near end

• Mx = A/B where A = distance (fulcrum to stylus), B = distance (fulcrum to tissue attachment)
• Slow-contracting tissue → high magnification (10-15×) (small movements amplified)
• Fast-contracting tissue → low magnification (5-10×) (prevents writing off the drum)

---

SECTION 9: IMPORTANT PRACTICAL POINTS

---

• Resting tension = initial stretch applied to the tissue when it is mounted in the organ bath
• Applied by adjusting the lever or using calibrated weights
• Purpose:
  1. Keeps the tissue at its optimal length for contraction (length-tension relationship)
  2. Prevents spontaneous movement artifacts
  3. Ensures the tissue is taut enough to pull the lever when it contracts
• Typical values:
  • Rat uterus: 0.5-1 g
  • Guinea pig ileum: 0.5-1 g
  • Rat fundus: 1 g
  • Frog rectus abdominis: 0.5 g
  • Frog heart: 0.2-0.5 g (very gentle - don't overstretch)

---

• Equilibration = period of 30-45 minutes during which the isolated tissue is allowed to stabilize in the organ bath before drug testing begins
• During this time, the PSS is changed every 10-15 minutes
• Purpose:
  1. Allows the tissue to adapt to the in vitro temperature, ionic environment, and oxygenation
  2. Washes out any endogenous mediators released during dissection trauma (histamine, K⁺, etc.)
  3. Allows the resting tension to stabilize
  4. Ensures baseline spontaneous activity (or absence thereof) is predictable
• A stable baseline before the first drug dose is essential for a valid experiment

---

• Dose cycle = the minimum time between two successive drug additions to the bath
• Includes at least 2 complete PSS washes of the bath before the next dose
• Fast contracting tissues: 3 minutes
• Slow contracting tissues: 5 minutes

• Tissue does not fully recover to baseline → next response is measured from a different starting point → inaccurate response measurement
• Residual drug remains in bath → responses appear cumulative or exaggerated
• Tachyphylaxis may develop faster
• Results become non-reproducible

---

• Contact time = the duration for which the drug remains in contact with the tissue before the bath is washed
• Typically: 1-2 minutes for most preparations (time for the drug to produce its maximum response, then wash)
• If contact time is too long: tachyphylaxis, irreversible effects
• If too short: incomplete response not at peak

---

QUICK SUMMARY TABLE: All Isolated Tissue Preparations

---

---

IN VITRO EXPERIMENTAL STUDY: ORGAN BATH, PSS, LEVERS, MAGNIFICATION & OTHER IMPORTANT POINTS

Viva Questions & Answers - MD Pharmacology

---

SECTION 1: ORGAN BATH - DEFINITION, HISTORY, TYPES

---

• First designed and developed by Rudolph Magnus in 1904
• It was subsequently used by Otto Loewi to discover acetylcholine as the first neurotransmitter (the famous "Vagusstoff" experiment on isolated frog hearts), for which Loewi shared the 1936 Nobel Prize in Physiology or Medicine with Sir Henry Dale
• Magnus's original design remains the basis of the organ bath used in pharmacology laboratories today

---

• Designed and developed by Rudolph Magnus
• Has one inner organ bath
• Standard for teaching laboratories and routine experiments

• Has two or more inner tissue baths within the same outer water jacket
• Allows simultaneous recording from multiple tissue preparations
• Used for more efficient and faster drug discovery in the pharmaceutical industry
• Reduces inter-experiment variability (same temperature, same PSS batch)

• Classical: mechanical recording on smoked paper kymograph drum via lever
• Modern: force transducers connected to digital data acquisition systems (PowerLab, AD Instruments, Biopac)
• Principle is identical; only the recording method differs

---

A. OUTER BATH (Water Jacket)

• Made of steel, perspex glass, or glass
• Surrounds the inner organ bath on all sides
• Contains water (not PSS)
• Purpose: acts as a thermostat/heat reservoir to maintain stable temperature of the inner bath
• Has a water heater/heating coil fitted inside to heat the water
• Has a thermostat to maintain constant pre-set temperature (e.g., 37°C for mammalian tissues)
• Has a rotator/stirrer that circulates water throughout the jacket to maintain uniform temperature

B. INNER ORGAN BATH

• Made of glass (transparent for observation)
• Capacity: 10 to 50 mL (typically 25 mL for most preparations)
• Contains the PSS in which the isolated tissue is immersed
• Has an inlet (at the bottom) for filling with fresh PSS
• Has an outlet/drain for emptying during washes
• The tissue hangs inside it, attached between the tissue holder at the bottom and the lever above

C. INDIVIDUAL COMPONENTS IN DETAIL:

• Made of steel or perspex; stores water to maintain temperature of the inner bath

• Glass vessel; contains PSS and the mounted tissue

• Fitted in the outer organ bath
• Heats the water in the outer bath to the required temperature

• Maintains the water in the outer bath at a constant, pre-set temperature
• Prevents overheating or cooling

• Circulates the water in the outer jacket
• Ensures uniform temperature throughout the outer bath (no hot/cold spots)

• Also called the aspiration bottle
• Named after French physicist Edme Mariotte
• Functions as the reservoir for PSS
• Delivers PSS at a constant flow rate from a closed bottle (using atmospheric pressure principle)
• Connected to the inner organ bath via glass tubing and a pre-heating coil

• Dual-purpose glass tube inside the inner organ bath
• Supplies continuous O₂/air/carbogen to oxygenate the PSS (via fine bubbles)
• Also serves as the tissue holder - the lower thread of the tissue is attached to the bottom hook of this tube

• Fixed pivot point to which the writing lever is attached
• Allows free vertical movement of the lever so that tissue contractions are transmitted to the writing point
• Usually attached to the organ bath stand outside the bath

• Glass coil connecting the Mariotte bottle reservoir to the inner organ bath
• Its capacity is usually double that of the inner organ bath
• As PSS flows from the reservoir through this coil (which sits inside the outer water bath), it warms to the bath temperature before entering the inner organ bath
• Purpose: prevents cold PSS from suddenly chilling the tissue during refilling
• Also maintains temperature of PSS when the outer organ bath is temporarily empty

• Mechanical instrument used for recording tissue responses (described in detail below)

• Records and preserves the tissue responses over time (described in detail below)

---

SECTION 2: KYMOGRAPH

---

1. Recording drum - a cylindrical drum that rotates at controlled speed
2. Drum surface - covered with smoked paper (traditional) or smooth/glossy paper; the glossy/smooth side faces outward for the lever to write on
3. Speed control knob - adjusts rotation speed
4. Drive motor - rotates the drum at the set speed
5. Clamp/stand - holds the drum at the correct height and position relative to the lever

• The drum rotates continuously at a set speed
• The stylus of the recording lever rests against the drum surface
• As the tissue contracts or relaxes, the lever moves up and down, writing a trace on the rotating drum
• The result is a continuous recording of tissue response vs. time (a waveform on paper)

• Standard speed: 1 revolution per 96 minutes = 0.014 rpm
• Slow speed (low rpm): used for slow-contracting tissues (uterus, fundus strip) - gives a widely spaced trace
• Fast speed (high rpm): used for fast-contracting tissues (ileum, colon) - gives closely spaced cycles but separates individual responses clearly

• Traditional kymographs use smoked paper (paper with a layer of lamp black/soot)
• The lever stylus scratches through the soot to produce a white trace on a black background
• After recording, the trace is fixed with shellac varnish
• Modern versions use smooth/glossy paper with ink-writing levers

---

SECTION 3: RECORDING LEVER

---

• Made of aluminum or stainless steel
• Must be: very light, fine, and rigid
  • Light: so its own weight does not dampen or distort tissue responses (the tissue must be able to lift it)
  • Fine: for sensitive recording
  • Rigid: so it does not bend while writing (bending would cause the stylus to lift off the drum surface, giving an inaccurate trace)

---

TYPES OF LEVERS

• Type 1 lever is the standard lever used in all in vitro isolated tissue organ bath bioassays
• The tissue is attached at one end (load/effort arm), fulcrum is in the middle, and stylus writes at the other end (resistance arm)

1. Frontal writing lever:
   • Stylus writes on the front surface of the drum
   • More commonly used
   • Gives a direct visual trace
2. Lateral writing lever:
   • Less common; writes on the side of the drum

---

PARTS OF THE LEVER

1. Effort arm (Input arm): The arm where the tissue is attached via thread - this is where the contractile force is applied
2. Fulcrum: The pivot point around which the lever rotates; attached to the organ bath stand; allows free vertical movement to record responses
3. Resistance arm (Output arm): The arm bearing the stylus (writing point) that writes on the kymograph drum
4. Stylus: Fine writing point at the tip of the resistance arm; rests against the drum surface

---

SECTION 4: MAGNIFICATION

---

Mx = A / B where:

• A = distance from the fulcrum to the stylus (writing point) - the longer arm
• B = distance from the fulcrum to the tissue attachment point - the shorter arm

• If A = 10 cm and B = 1 cm → Mx = 10 (10-fold magnification)
• A 1 mm tissue contraction will produce a 10 mm deflection on the drum

---

• Too high Mx with fast tissue → stylus goes off the drum (off-scale)
• Too low Mx with slow tissue → trace is too small to measure accurately

---

• The longer the resistance arm (A) relative to the effort arm (B), the greater the magnification
• Greater magnification = more sensitive recording (smaller movements amplified)
• BUT: excessively long resistance arms make the lever heavy → increased inertia → may dampen fast contractions or cause the stylus to lag behind
• Therefore, the lever must be as light as possible while still being rigid, so that increasing arm length (magnification) does not increase inertia

---

SECTION 5: PHYSIOLOGICAL SALT SOLUTION (PSS)

---

1. Ionic supply: Provides Na⁺, K⁺, Ca²⁺, Mg²⁺, Cl⁻ in physiological proportions to maintain resting membrane potential, action potentials, and excitation-contraction coupling
2. Nutritional supply: Glucose provides energy (ATP) via cellular respiration
3. Osmotic balance: Prevents cell swelling or shrinkage
4. pH maintenance: Bicarbonate and phosphate buffer systems maintain pH 7.3-7.4
5. Sustained viability: Keeps the tissue alive and responsive for the duration of the experiment

• Always prepared in distilled water, double-distilled water, or deionized water (tap water contains contaminants)
• Must be prepared fresh (do not store for long periods - bacterial contamination and chemical degradation)
• pH must be maintained at 7.3-7.4
• Must be free of particulate matter

---

"De-Jalon, Frog Ringer, and Ringer-Locke do NOT contain Mg²⁺ or Phosphate"

---

• De-Jalon vs Ringer-Locke: Same composition EXCEPT De-Jalon has ¼ the CaCl₂ and ½ the glucose of Ringer-Locke
• Frog Ringer: Can be made by adding 400 mL distilled water to 1 L of Ringer-Locke (dilutes it to amphibian tonicity)
• McEwen solution: Same as Krebs but also contains sucrose (in addition to glucose)

---

Selection by Tissue Type:

Selection Rules:

• Tyrode → for non-innervated mammalian smooth muscles
• Krebs → for innervated muscles (nerve-muscle preparations); "gold standard" - can be used for ANY tissue
• Frog Ringer → for all amphibian tissues
• Ringer-Locke → for isolated mammalian heart (cardiac preparation)
• De-Jalon → specifically for rat uterus

---

1. Provides O₂ for aerobic cellular respiration → ATP production → sustained contractile activity
2. The CO₂ component (when carbogen is used) reacts with NaHCO₃ in the PSS to form the bicarbonate buffer system → maintains pH 7.3-7.4
3. Gentle bubbling creates mild turbulence → distributes drug uniformly throughout the bath when added
4. Prevents stagnation and ensures fresh oxygenated PSS around the tissue

• Pure O₂ interacts with the bicarbonate (HCO₃⁻) in PSS
• O₂ displaces CO₂ → the equilibrium shifts: HCO₃⁻ + H⁺ → H₂CO₃ → H₂O + CO₂ (CO₂ driven off)
• This results in the PSS becoming excessively alkaline (pH rises above 7.4)
• Therefore, Krebs and McEwen must be aerated with carbogen (which maintains CO₂ tension and thus pH)

---

1. Use only distilled, double-distilled, or deionized water - never tap water
2. Maintain pH = 7.3-7.4 (check with pH meter before use)
3. Prepare fresh on the day of the experiment
4. Add components in the correct order - add CaCl₂ last (if added to concentrated NaHCO₃/phosphate, it precipitates as CaCO₃ or Ca₃(PO₄)₂)
5. Weigh accurately - error should be less than 1%
6. Equilibrate/aerate with appropriate gas before placing tissue
7. Maintain at the correct temperature during the experiment
8. Never reuse PSS that has been in contact with tissue - it may contain released mediators

---

SECTION 6: RESTING TENSION / LOAD

---

1. Length-tension relationship: Muscle develops maximum active tension at a specific resting length (optimal length, L₀). Applying resting tension places the tissue at or near this optimal length where cross-bridge overlap is maximal → best contractile response
2. Prevents slack: Without resting tension, the tissue hangs loose and the lower portion of contraction is wasted taking up slack before the lever moves
3. Baseline stability: Prevents random drift of the lever due to tissue weight
4. Reproducibility: Ensures the same starting conditions for every dose in the experiment

---

SECTION 7: DOSE CYCLE, CONTACT TIME, EQUILIBRATION

---

• PSS is changed every 10-15 minutes (3-4 washes total)
• Resting tension is checked and adjusted if it drifts
• Baseline spontaneous activity (if any) is allowed to stabilize

1. Allows the tissue to adapt to in vitro temperature, oxygenation, and ionic environment
2. Washes out endogenous mediators released during dissection trauma (histamine, K⁺, prostaglandins, adrenaline) which would contaminate baseline and early drug responses
3. Allows the tissue to equilibrate metabolically - restores ATP stores
4. Establishes a stable, reproducible baseline (essential for accurate measurement of drug responses)
5. Identifies any spontaneous activity (some tissues like rat uterus have spontaneous contractions; these must be characterized before starting drug additions)

---

• Ensures complete removal of the previous drug dose by washing
• Allows the tissue to fully return to baseline before the next dose
• Prevents cumulative drug effects distorting the response
• Minimizes tachyphylaxis (if the tissue is not allowed to recover, repeated exposure accelerates receptor desensitization)
• Ensures each response is independent and comparable

• Residual drug → next response is not a pure response to the new dose
• Baseline never fully recovers → responses measured from different starting points → non-reproducible results
• Tachyphylaxis develops faster

---

• Typically 30 seconds to 2 minutes for most preparations
• Must be long enough for the drug to produce its peak response
• Then the bath is washed out immediately to prevent:
  • Irreversible drug-receptor binding (some drugs)
  • Tachyphylaxis from prolonged exposure
  • Damage to tissue viability

• Contact time = how long drug stays
• Dose cycle = total time from one dose to the next (includes contact time + washout + baseline recovery)

---

SECTION 8: TACHYPHYLAXIS

---

• Receptor desensitization/downregulation: Receptor becomes unresponsive after repeated activation (e.g., receptor phosphorylation, internalization)
• Depletion of mediator stores: For indirectly acting drugs (e.g., tyramine depletes noradrenaline from sympathetic nerve terminals)
• Receptor saturation and uncoupling

• Repeated doses of histamine on guinea pig ileum → progressive reduction in contraction height
• Repeated doses of 5-HT on rat fundus
• Repeated doses of tyramine on rabbit aorta

1. Allow adequate dose cycle time (3-5 min with at least 2 washes)
2. Use lower concentrations where possible
3. Avoid drugs known to cause severe tachyphylaxis for assays requiring many repeated doses
4. Standardize the tissue response at the start of each dose cycle by using a reference dose (a standard dose between each test dose) to monitor tissue sensitivity

• If the tissue loses sensitivity, the dose-response relationship changes
• Responses to the same standard dose at the beginning vs. end of the experiment will differ → the assay is invalid
• This is why many standard doses are interleaved throughout the experiment to track and correct for tissue drift

---

SECTION 9: ISOMETRIC vs ISOTONIC RECORDING

---

• Classical organ bath experiments in pharmacology teaching use isotonic recording (tissue shortens and moves the lever)
• Modern research uses isometric force transducers (more precise, digital)

---

SECTION 10: COMMON ERRORS AND TROUBLESHOOTING

---

---

SECTION 11: DRUGS AND THEIR ORGAN BATH RESPONSES

---

• Histamine: contraction (H₁ receptor mediated)
• ACh: contraction (muscarinic M₃ receptor)
• Atropine: blocks ACh-induced contraction (muscarinic antagonist)
• Mepyramine (pyrilamine): blocks histamine-induced contraction (H₁ antagonist)
• Morphine: inhibits ACh release (presynaptic opioid receptors) → reduces contractility

• Oxytocin: contraction (oxytocin receptor)
• Ergotamine/ergometrine: contraction (direct smooth muscle effect)
• Adrenaline: relaxation (β₂ receptor on uterine smooth muscle)
• Salbutamol: relaxation (β₂ agonist - tocolytic effect)

• 5-HT (serotonin): contraction (5-HT₂ receptor)
• Histamine: no significant response (fundus is insensitive to histamine - important differentiating feature)
• Ketanserin: blocks 5-HT-induced contraction (5-HT₂ antagonist)

• ACh: contraction (nicotinic receptor at neuromuscular junction)
• d-Tubocurarine: blocks ACh-induced contraction (competitive nicotinic antagonist)
• Neostigmine: potentiates ACh response (anticholinesterase)

• Adrenaline: increased rate + force (positive chronotropic + inotropic)
• ACh: decreased rate + force (negative chronotropic + inotropic - vagal effect)
• Digoxin: increased force (positive inotropic) + slowed rate at higher doses (cardiac arrest)
• KCl (excess): cardiac arrest in diastole (depolarization block)
• CaCl₂ (excess): cardiac arrest in systole (calcium rigor)

---

COMPLETE SUMMARY: ORGAN BATH SETTINGS FOR EACH PREPARATION

---